Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children

Phase 4 Study: Milk Oral Immunotherapy for Cow's Milk Allergy in School-aged Children

The purpose of this study is to study the number of Participants with Adverse Events as a Measure of Safety and Tolerability.

Eligibility criteria:

Age 6 - 16 yrs

• IgE-mediated milk allergy
• and milk provocation within 3 months prior to or an documented accidental milk contact with clear immediate symptoms

Outcome measures:

• number of patients with successful desensitization (195 - 200 ml milk per day)
• number of patients with adverse events

Inclusion Criteria:

• IgE-mediated milk allergy
• An immediately positive challenge test result to milk prior to inclusion

Exclusion Criteria:

• Not willing to participate